Michael Richman - Jan 31, 2024 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
President & CEO, Director
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Michael Richman
Stock symbol
NXTC
Transactions as of
Jan 31, 2024
Transactions value $
$0
Form type
4
Date filed
2/1/2024, 04:45 PM
Previous filing
Jun 23, 2023
Next filing
Apr 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Employee Stock Option (Right to Buy) Award $0 +306K $0.00 306K Jan 31, 2024 Common Stock 306K $1.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth of the option vests on January 31, 2025. The remainder vests in 36 monthly installments beginning on February 28, 2025.